This finding was in line with the reported increase in cell doubling times of TP53 knockdown BAR-T cells46 and supported the tumor-preventive role of early CDKN2A inactivation due to the reduced fitness, defined as proliferative capacity, of cells additionally losing TP53. The gene discussed is TP53; the disease is neoplasm.